The well of novel antidepressants: running dry
- PMID: 20569647
- PMCID: PMC2895150
- DOI: 10.1503/jpn.100098
The well of novel antidepressants: running dry
Comment in
-
Possible directions for the discovery of new antidepressant treatments.J Psychiatry Neurosci. 2011 Jan;36(1):3-5. doi: 10.1503/jpn.100169. J Psychiatry Neurosci. 2011. PMID: 21167108 Free PMC article. No abstract available.
Similar articles
-
[Clinical studies: the missing antidepressants].Neuropsychopharmacol Hung. 2005 Sep;7(3):103-4. Neuropsychopharmacol Hung. 2005. PMID: 16493873 Hungarian. No abstract available.
-
Qualms about balms: perspectives on antidepressants.J Nerv Ment Dis. 2001 May;189(5):296-8. doi: 10.1097/00005053-200105000-00004. J Nerv Ment Dis. 2001. PMID: 11379972 No abstract available.
-
Agomelatine: innovation for the benefit of depressed patients.CNS Drugs. 2009;23 Suppl 2:1-2. doi: 10.2165/11318610-000000000-00000. CNS Drugs. 2009. PMID: 19708720 No abstract available.
-
[If the general practitioner has to decide: what is the evidence for the selection of antidepressants?].Dtsch Med Wochenschr. 2014 Aug;139(34-35):1727-30. doi: 10.1055/s-0034-1370270. Epub 2014 Aug 12. Dtsch Med Wochenschr. 2014. PMID: 25116024 Review. German.
-
[Melatoninergic antidepressant valdoxan].Eksp Klin Farmakol. 2011;74(7):41-5. Eksp Klin Farmakol. 2011. PMID: 21894769 Review. Russian.
Cited by
-
Inflaming depression.J Psychiatry Neurosci. 2011 Sep;36(5):291-5. doi: 10.1503/jpn.110071. J Psychiatry Neurosci. 2011. PMID: 21864468 Free PMC article. No abstract available.
-
A Canadian Primary Care Sentinel Surveillance Network Study Evaluating Antidepressant Prescribing in Canada From 2006 to 2012.Can J Psychiatry. 2015 Dec;60(12):564-70. doi: 10.1177/070674371506001207. Can J Psychiatry. 2015. PMID: 26720825 Free PMC article.
-
Orphans to the rescue: orphan G-protein coupled receptors as new antidepressant targets.J Psychiatry Neurosci. 2020 Sep 1;45(5):301-303. doi: 10.1503/jpn.200149. J Psychiatry Neurosci. 2020. PMID: 32820877 Free PMC article. No abstract available.
-
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review.Neuropsychiatr Dis Treat. 2016 Mar 31;12:719-35. doi: 10.2147/NDT.S100846. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27099503 Free PMC article. Review.
-
Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.J Psychiatry Neurosci. 2011 Nov;36(6):375-82. doi: 10.1503/jpn.100117. J Psychiatry Neurosci. 2011. PMID: 21463543 Free PMC article. Clinical Trial.
References
-
- Kennedy SH. Agomelatine: efficacy at each phase of antidepressant treatment. CNS Drugs. 2009;23(Suppl 2):41–7. - PubMed
-
- Joubert AF, du Plessis AD, Farles D, et al. High placebo response rate versus clinical impression with the new antidepressant duloxetine. Biol Psychiatry. 1997;42(Suppl 1):229S.
-
- Nemeroff CB, Schatzberg AF, Goldstein DJ, et al. Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull. 2002;36:106–32. - PubMed
-
- Sánchez C, B⊘ges⊘ KP, Ebert B, et al. Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology (Berl) 2004;174:163–76. - PubMed
-
- Lobello KW, Preskorn SH, Guico-Pabia CJ, et al. Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder. J Clin Psychiatry. 2010 Apr 6; [Epub ahead of print] - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical